Because the public bears such a large percentage of health care costs, physicians are coming under increasing pressure to provide care that is not only skilled and compassionate but also cost-effective. Out-come analysis and cost-benefit ratios are buzzwords of the 1990s. In this issue of the Archives, Kassoff and Meyer1 have addressed the issue of cost-effectiveness in the management of congenital nasolacrimal duct obstruction using a technique called clinical decision analysis and have provided us with important and useful information. They have concluded that early office-based probing is substantially more cost-effective than a later, hospital-based procedure. Although cost is an important consideration for decision making by patients and physicians, other factors that I will discuss below need to be part of the equation. To paraphrase the noted physicist, Nehls Bohr, "The opposite of a false statement is a true statement, but the opposite of a true statement may be
Kushner BJ. Early Office-Based vs Late Hospital-Based Nasolacrimal Duct Probing. Arch Ophthalmol. 1995;113(9):1103–1104. doi:10.1001/archopht.1995.01100090025015
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: